Cross-recognition of HLA DR4 alloantigen by virus-specific CD8+ T cells: a new paradigm for self-/nonself-recognition.

The ability of CD8(+) T cells to engage a diverse range of peptide-major histocompatibility complex (MHC) complexes can also lead to cross-recognition of self and nonself peptide-MHC complexes and thus directly contribute toward allograft rejection or autoimmunity. Here we present a novel form of cross-recognition by herpes virus-specific CD8(+) cytotoxic T cells that challenges the current paradigm of self/non-self recognition. Functional characterization of a human leukocyte antigen (HLA) Cw*0602-restricted cytomegalovirus-specific CD8(+) T-cell response revealed an unusual dual specificity toward a pp65 epitope and the alloantigen HLA DR4. This cross-recognition of HLA DR4 alloantigen was critically dependent on the coexpression of HLA DM and was preferentially directed toward the B-cell lineage. Furthermore, allostimulation of peripheral blood lymphocytes with HLA DRB*0401-expressing cells rapidly expanded CD8(+) T cells, which recognized the pp65 epitope in the context of HLA Cw*0602. T-cell repertoire analysis revealed 2 dominant populations expressing T-cell receptor beta variable (TRBV)4-3 or TRBV13, with cross-reactivity exclusively mediated by the TRBV13(+) clonotypes. More importantly, cross-reactive TRBV13(+) clonotypes displayed markedly lower T-cell receptor binding affinity and a distinct pattern of peptide recognition, presumably mimicking a structure presented on the HLA DR4 allotype. These results illustrate a novel mechanism whereby virus-specific CD8(+) T cells can cross-recognize HLA class II molecules and may contribute toward allograft rejection and/or autoimmunity.

[1]  L. Gerber,et al.  Human lymphocyte antigens characterizing psoriatic arthritis and its subtypes. , 1982, The Journal of rheumatology.

[2]  D. Gladman,et al.  HLA antigens in psoriatic arthritis. , 1986, The Journal of rheumatology.

[3]  P. Cresswell,et al.  Impaired assembly and transport of HLA‐A and ‐B antigens in a mutant TxB cell hybrid. , 1986, The EMBO journal.

[4]  P. Gregersen,et al.  Molecular diversity of HLA-DR4 haplotypes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Palmiter,et al.  The effect of thymus environment on T cell development and tolerance , 1988, Cell.

[6]  S. Jameson,et al.  Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor , 1989, Nature.

[7]  M. Bevan,et al.  Role of self-peptides in positively selecting the T-cell repertoire , 1990, Nature.

[8]  A. Rudensky,et al.  On the complexity of self , 1991, Nature.

[9]  L. Steinman,et al.  Analysis of the T cell repertoire using the PCR and specific oligonucleotide primers. , 1992, BioTechniques.

[10]  E. Kieff,et al.  Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development , 1992, The Journal of experimental medicine.

[11]  M F del Guercio,et al.  HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. , 1993, Journal of immunology.

[12]  C. Janeway,et al.  Thymic selection: two pathways to life and two to death. , 1994, Immunity.

[13]  C. Eastmond Psoriatic arthritis. Genetics and HLA antigens. , 1994, Bailliere's clinical rheumatology.

[14]  Kristin A. Hogquist,et al.  T cell receptor antagonist peptides induce positive selection , 1994, Cell.

[15]  P. Doherty,et al.  CD8+ T-cell memory to viruses. , 1994, Current opinion in immunology.

[16]  C. Eastmond Genetics and HLA antigens , 1994 .

[17]  J. Burrows,et al.  An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease , 1994, The Journal of experimental medicine.

[18]  A. Rolink,et al.  Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor , 1994, The Journal of experimental medicine.

[19]  R. Karr,et al.  Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association , 1995, The Journal of experimental medicine.

[20]  D. Zaller,et al.  Lyme disease in human DR4Dw4-transgenic mice. , 1995, The Journal of infectious diseases.

[21]  H. Ishibashi,et al.  Hla Drb4 0101-restricted Immunodominant T Cell Autoepitope of Pyruvate Dehydrogenase Complex in Primary Biliary Cirrhosis: Evidence of Molecular Mimicry in Human Autoimmune Diseases , 1995 .

[22]  S. L. Silins,et al.  T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen , 1995, The Journal of experimental medicine.

[23]  J. McCluskey,et al.  Cross‐reactive memory T cells for Epstein‐Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex‐bound peptide by T cells and its role in alloreactivity , 1997, European journal of immunology.

[24]  P. Doherty,et al.  Effector CD4+ and CD8+ T‐cell mechanisms in the control of respiratory virus infections , 1997, Immunological reviews.

[25]  V. Brusic,et al.  Neural network-based prediction of candidate T-cell epitopes , 1998, Nature Biotechnology.

[26]  K. Garcia,et al.  Structural basis of T cell recognition. , 1999, Annual review of immunology.

[27]  S. Burrows,et al.  Direct alloreactivity by human cytotoxic T lymphocytes can Be inhibited by altered peptide ligand antagonism. , 1999, Blood.

[28]  S. L. Silins,et al.  The influence of antiviral T-cell responses on the alloreactive repertoire. , 1999, Immunology today.

[29]  R. Zinkernagel,et al.  Immunological Memory , 2006 .

[30]  F. Koning,et al.  Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  L. Moretta,et al.  HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Menzies,et al.  Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus Carriers , 2003, Journal of Virology.

[33]  Anajane G. Smith,et al.  Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain , 2004, Immunogenetics.

[34]  R. Khanna,et al.  Cross-recognition of human alloantigen by cytomegalovirus glycoprotein-specific CD4+ cytotoxic T lymphocytes: implications for graft-versus-host disease. , 2005, Blood.

[35]  S. Jameson,et al.  Central tolerance: learning self-control in the thymus , 2005, Nature Reviews Immunology.

[36]  P. Doherty,et al.  Structural determinants of T-cell receptor bias in immunity , 2006, Nature Reviews Immunology.

[37]  L. K. Ely,et al.  T cell allorecognition and MHC restriction--A case of Jekyll and Hyde? , 2008, Molecular immunology.

[38]  J. McCluskey,et al.  T-cell allorecognition: a case of mistaken identity or déjà vu? , 2008, Trends in immunology.

[39]  S. Sainsbury,et al.  T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. , 2009, Immunity.

[40]  L. K. Ely,et al.  Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition , 2009, The Journal of experimental medicine.

[41]  Anajane G. Smith,et al.  Ten HLA-DR 4 alleles defined by sequence polymorphisms within the DRB 1 first domain , 2022 .